Evidence map›Paper›PMID 24471430›Full record

ReviewAnnual review of immunology2014

Transcriptional control of early T and B cell developmental choices.

Ellen V Rothenberg

Open access · greenAbstract readReview
In one paragraph

Review in Annual review of immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 139 papers.

0numbers the graph read from it
0cells of the map it votes in
139citing papers in PubMed
9.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

139 citing papers in PubMed, 214 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. PervasivebioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Therapeutic targeting of the NOTCH1 and neddylation pathways in T cell acute lymphoblastic leukemia.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  12. MultiplexedbioRxiv : the preprint server for biology · 2025
    Article
  13. Review
  14. T Cell Development: From T-Lineage Specification to Intrathymic Maturation.Advances in experimental medicine and biology · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

79 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Ellen V RothenbergDivision of Biology, California Institute of Technology, Pasadena, California 91125; email: evroth@its.caltech.edu.
California Institute of Technology · US

Funding

LINEAGE COMMITMENT MECHANISMS IN LYMPHOID PRECURSORSR01CA090233 · NCI · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ROTHENBERG, ELLEN V. · 2001 to 2011
$3.9M
Key nodes in the T-cell developmental gene regulatory networkR01AI095943 · NIAID · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ROTHENBERG, ELLEN V. · 2011 to 2015
$2.0M
Bcl11b in early T cell developmentR01AI083514 · NIAID · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ROTHENBERG, ELLEN V. · 2011 to 2015
$1.8M
Reverse engineering genetic network architecture of stem-cell/lymphocyte transitiR33HL089123 · NHLBI · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ROTHENBERG, ELLEN V. · 2007 to 2009
$1.6M
Dynamic Epigenetic Mapping of a Stem Cell Differentiation ChoiceRC2CA148278 · NCI · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ROTHENBERG, ELLEN V., WOLD, BARBARA J · 2009 to 2010
$1.6M
Bcl11b in early T cell developmentR56AI083514 · NIAID · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ROTHENBERG, ELLEN V. · 2010 to 2010
$405k
NCI NIH HHS CA148278NCI NIH HHS CA90233NCI NIH HHS R01 CA090233NCI NIH HHS RC2 CA148278NHLBI NIH HHS HL89123NHLBI NIH HHS R33 HL089123NIAID NIH HHS AI83514NIAID NIH HHS AI95943NIAID NIH HHS R01 AI083514NIAID NIH HHS R01 AI095943NIAID NIH HHS R56 AI083514
6 · The paper itself

Abstract

T and B cells share a common somatic gene rearrangement mechanism for assembling the genes that code for their antigen receptors; they also have developmental pathways with many parallels. Shared usage of basic helix-loop-helix E proteins as transcriptional drivers underlies these common features. However, the transcription factor networks in which these E proteins are embedded are different both in membership and in architecture for T and B cell gene regulatory programs. These differences permit lineage commitment decisions to be made in different hierarchical orders. Furthermore, in contrast to B cell gene networks, the T cell gene network architecture for effector differentiation is sufficiently modular so that E protein inputs can be removed. Complete T cell-like effector differentiation can proceed without T cell receptor rearrangement or selection when E proteins are neutralized, yielding natural killer and other innate lymphoid cells.

Indexed as

Transcription, GeneticAnimalsBasic Helix-Loop-Helix ProteinsB-LymphocytesCell DifferentiationCell LineageGene Expression Regulation, DevelopmentalHumansLymphoid Progenitor CellsLymphopoiesisPhenotypeReceptors, NotchT-LymphocytesBasic Helix-Loop-Helix ProteinsReceptors, Notch

Identifiers

PMID24471430
PMCPMC3994230
OpenAlexW2127754056

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.